Drug Profile
Hepatitis E vaccine recombinant - Xiamen Innovax
Alternative Names: Hecolin; HEV 239Latest Information Update: 09 Nov 2020
Price :
$50
*
At a glance
- Originator Xiamen Innovax Biotech
- Class Synthetic vaccines; Viral hepatitis vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hepatitis E